Interleukin-25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL-17RB, but not IL-17RA

Clinical and Experimental Allergy

Volumn 42, Issue 11, 2012, Pages 1604-1614

  Wang, W ^a,b   Fan, Y Q ^a   Lv, Z ^a   Yao, X J ^a,b   Huang, K W ^b   Meng, Q ^c   Fang, C L ^c   Lee, T H ^c   Corrigan, C J ^c   An, Y Q ^a   Ying, S ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Basic fibroblast growth factor; Endothelial cells; IL 25; IL 25 receptor; Remodelling

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 25; PHOSPHATIDYLINOSITOL 3 KINASE;

ANGIOGENESIS; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROVASCULAR ENDOTHELIAL CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING;

CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-17; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 84868142434     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04062.x     Document Type: Article

References (31)

1. Fort MM, Cheung J, Yen D et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15:985-95.
2. Dong C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 2008; 226:80-6.
3. Hurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169:443-53.
4. Pan G, French D, Mao W et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001; 167:6559-67.
5. Kim MR, Manoukian R, Yeh R et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002; 100:2330-40.
6. Ballantyne SJ, Barlow JL, Jolin HE et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120:1324-31.
7. Angkasekwinai P, Park H, Wang YH et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204:1509-17.
8. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC- activated Th2 memory cells. J Exp Med 2007; 204:1837-47.
9. Ikeda K, Nakajima H, Suzuki K et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003; 101:3594-6.
10. Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C. Regulation of IL-9 expression by IL-25 signalling. Nat Immunol 2010; 11:250-6.
11. Wong CK, Cheung PF, Ip WK, Lam CW. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005; 33:186-94.
12. Caruso R, Stolfi C, Sarra M et al. Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 2009; 113:3512-9.
13. Rickel EA, Siegel LA, Yoon BR et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008; 181:4299-310.
14. Gaffen SL. Structure and signalling in the IL-17 receptor superfamily. Nat Rev Immunol 2009; 9:556-67.
15. Lajoie-Kadoch S, Joubert P, Létuvé S et al. TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1238-46.
16. Létuvé S, Lajoie-Kadoch S, Audusseau S et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006; 117:590-6.
17. Corrigan CJ, Wang W, Meng Q et al. T-helper cell type 2 (Th2) memory T cell-protentiating cytokine 25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci USA 2011; 108:1579-84.
18. Corrigan CJ, Wang W, Meng Q et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 2011; 128:116-24.
19. Bosse Y, Rola-Pleszczynski M. FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends Mol Med 2008; 14:3-11.
20. Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest 1999; 79:395-405.
21. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107:295-301.
22. Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 1999; 274:12611-8.
23. Lei JT, Martinez-Moczygemba M. Separate endocytic pathways regulate IL-5 receptor internalization and signaling. J Leukocyte Biol 2008; 84:499-509.
24. Houle F, Chan C, Yao Y et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010; 84:4531-7.
25. Takahashi H, Numasaki M, Lotze MT, Sasaki H. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 2005; 98:189-93.
26. Numasaki M, Fukushi J, Ono M et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101:2620-7.
27. Lee J, Ho WH, Maruoka M et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL17Rh1. J Biol Chem 2001; 276:1660-4.
28. Gratchev A, Kzhyshkowska J, Duperrier K, Utikal J, Velten FW, Goerdt S. The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells. Scand J Immunol 2004; 60:233-7.
29. Weylie B, Zhu J, Singh U, Ambrus S, Forough R. Phosphatidylinositide 3-kinase is important in late-stage fibroblast growth factor-1-mediated angiogenesis in vivo. J Vasc Res 2006; 43:61-9.
30. Wang Z, Jiang C, Ganther H, Lü J. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K- -AKT, ERK, JNK and p38 MAPK signaling. Cancer Res 2001; 61:7171-8.
31. Park SJ, Min KH, Lee YC. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma. Respirology 2008; 13:764-71.